Spectrum Pharmaceuticals, Inc. (SPPI), a biopharmaceutical company, has gained a 5.88% in premarket trading session and consequently is trading at $0.66 at the time of
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) has a beta of 2.19. The stock’s Relative Strength Index (RSI) is 62.90, with weekly volatility at 5.37% and ATR at
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) shares fell to a low of $4.30 before closing at $4.45. Intraday shares traded counted 1.68 million, which was 40.23% higher
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) Relative Strength Index (RSI) is 70.39, with weekly volatility at 4.96% and ATR at 0.17. The SPPI stock’s 52-week price range
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) has a beta of 2.22. The stock’s Relative Strength Index (RSI) is 60.22, with weekly volatility at 3.97% and ATR at
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) shares traded higher over the last trading session, gaining 0.93% on 05/25/21. The shares fell to a low of $3.21 before
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne
